1. Home
  2. APLE vs EWTX Comparison

APLE vs EWTX Comparison

Compare APLE & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apple Hospitality REIT Inc.

APLE

Apple Hospitality REIT Inc.

N/A

Current Price

$16.27

Market Cap

3.7B

Sector

Real Estate

ML Signal

N/A

Logo Edgewise Therapeutics Inc.

EWTX

Edgewise Therapeutics Inc.

N/A

Current Price

$39.14

Market Cap

4.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
APLE
EWTX
Founded
2007
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
4.3B
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
APLE
EWTX
Price
$16.27
$39.14
Analyst Decision
Buy
Buy
Analyst Count
11
13
Target Price
$17.17
★ $52.62
AVG Volume (30 Days)
★ 2.1M
1.4M
Earning Date
11-05-2026
11-05-2026
Dividend Yield
★ 5.92%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.40
N/A
Revenue
★ $1,238,622,000.00
N/A
Revenue This Year
$2.81
N/A
Revenue Next Year
$2.12
N/A
P/E Ratio
$40.55
★ N/A
Revenue Growth
★ 18.98
N/A
52 Week Low
$10.85
$14.25
52 Week High
$17.28
$48.51

Technical Indicators

Market Signals
Indicator
APLE
EWTX
Relative Strength Index (RSI) 54.90 39.09
Support Level $15.99 $37.75
Resistance Level $17.21 $41.04
Average True Range (ATR) 0.29 1.95
MACD 0.03 -0.25
Stochastic Oscillator 58.17 22.30

Price Performance

Historical Comparison
APLE
EWTX

About APLE Apple Hospitality REIT Inc.

Apple Hospitality REIT Inc is a real estate investment trust that invests in income-producing real estate, majorly in the lodging sector, in the United States. It chiefly invests in upscale service hotels. All of the company's hotels operate under the Marriott or Hilton brands. Apple Hospitality has wholly-owned taxable REIT subsidiaries, which lease all of the company's hotels from wholly-owned qualified REIT subsidiaries. These hotels are managed under separate agreements with various hotel management companies that are unaffiliated with Apple Hospitality. The company derives its income from hotel revenue, its sole segment.

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The company's product candidates are Sevasemten, EDG-7500, EDG-003, and EDG-15400. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies, including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company's products are currently in different stages of their development, being developed to target key muscle proteins and modulators to address a broad array of muscle diseases.

Share on Social Networks: